Vascular angiotensin II receptor and calcium signaling in toadfish

Renin-angiotensin system in vertebrates: phylogenetic view of structure and function

Renin substrate, biological renin activity, and/or renin-secreting cells in kidneys evolved at an early stage of vertebrate phylogeny. Angiotensin (Ang) I and II molecules have been identified biochemically in representative species of all vertebrate classes, although variation occurs in amino acids at positions 1, 5, and 9 of Ang I. Variations have also evolved in amino acid positions 3 and 4 in some cartilaginous fish. Angiotensin receptors, AT₁ and AT₂ homologues, have been identified molecularly or characterized pharmacologically in nonmammalian vertebrates. Also, various forms of angiotensins that bypass the traditional renin-angiotensin system (RAS) cascades or those from large peptide substrates, particularly in tissues, are present. Nonetheless, the phylogenetically important functions of RAS are to maintain blood pressure/blood volume homeostasis and ion-fluid balance via the kidney and central mechanisms. Stimulation of cell growth and vascularization, possibly via paracrine action of angiotensins, and the molecular biology of RAS and its receptors have been intensive research foci. This review provides an overview of: (1) the phylogenetic appearance, structure, and biochemistry of the RAS cascade; (2) the properties of angiotensin receptors from comparative viewpoints; and (3) the functions and regulation of the RAS in nonmammalian vertebrates. Discussions focus on the most fundamental functions of the RAS that have been conserved throughout phylogenetic advancement, as well as on their physiological implications and significance. Examining the biological history of RAS will help us analyze the complex RAS systems of mammals. Furthermore, suitable models for answering specific questions are often found in more primitive animals.

Differential status of the renin-angiotensin system of silver sea bream (Sparus sarba) in different salinities

Silver sea bream (Sparus sarba) is extremely euryhaline and can survive in a wide range of salinities (0-70 per thousand). The status of the renin-angiotensin system (RAS) in sea bream adapted to different salinities was studied. As indicated by plasma Ang II levels, a suppressed status of the RAS was found to occur under brackish water conditions; while under hypersaline conditions, an activated RAS prevailed, especially in fish adapted to double strength seawater (70 per thousand). Captopril successfully blocked the conversion of Ang I to Ang II, causing a dramatic drop in plasma Ang II levels, and such decrease was accompanied by lowered plasma cortisol levels. The pattern of changes in branchial Na-K-ATPase activity in different salinities was similar to those of plasma Ang II and cortisol, suggesting a causal regulatory role of Ang II on branchial Na-K-ATPase activity. Intraperitoneal injection of Ang II elicited a dose-dependent increase in branchial Na-K-ATPase activity in both 33- and 6 per thousand-adapted sea bream, but a relatively more intense stimulation of enzyme activity occurred in hyposmotic-adapted fish. Abrupt hyposmotic transfer rapidly lowered plasma Ang II level but elevated branchial Na-K-ATPase and transiently elevated plasma cortisol, indicating that these parameters are not solely controlled by Ang II but are also influenced by other hormonal factors that change during salinity transfer. Blood volumes of both 33- and 6 per thousand-adapted sea bream exhibited high stability during short-term salinity transfers and after long-term salinity adaptation. Captopril significantly reduced resting blood pressure in both 33- and 6 per thousand-adapted sea bream, indicating that the RAS was involved in maintenance of resting blood pressure in both hyperosmotic and hyposmotic environments. Blood pressure was highly stable during abrupt salinity transfer and captopril blockade did not alter such stability. The vasopressive effect of angiotensins was more potent in 6 per thousand-adapted sea bream. These results showed that the RAS is involved in the maintenance of fluid and pressure homeostasis in sea bream and hyposmotic-adapted sea bream has an abated RAS status.

Corpuscles of Stannius secrete renin or an isorenin that regulates cardiovascular function in freshwater North American eels, Anguilla rostrata LeSueur

Dorsal aortic blood flow (DABF) and caudal venous blood flow (CVBF) were measured in free-swimming conscious freshwater (FW) North American eels (Anguilla rostrata) with Doppler-flow probes. DABF and CVBF increased in a dose-dependent manner following iv doses of [Asn(1), Val(5), Gly(9)]-angiotensin I (ANG I), [Asn(1), Val(5)]-angiotensin II (ANG II), and [Val(4)]-angiotensin III (ANG III) ranging from 5 to 50 ng x kg bw(-1). A minimum effective dose for ANG I and ANG II was 5 ng x kg bw(-1); that for ANG III was 10 ng x kg bw(-1). DABF and CVBF rates increased during the first 2 min and remained elevated for 20-50 min. Flow responses similar to those of ANG II in form and magnitude followed iv injections of extracts of corpuscles of Stannius (CS-EXT). Increases in DABF and CVBF following injections of ANG I, human renin substrate (hRS), and CS-EXT were all blocked by the angiotensin-converting enzyme inhibitor Captopril. Increases in DABF and CVBF which followed injections of hRS and CS-EXT were blocked completely by pepstatin A. [Sar(1), Val(5)]-ANG II (Sarile) blocked completely the DABF and CVBF responses to ANG II and CS-EXT, but the mammalian receptor antagonists losartan (AT1) and PD123319 (AT2) only partially blocked them. These findings support strongly the hypothesis that the corpuscles of Stannius secrete renin or isorenin and that the renin-angiotensin system regulates cardiovascular function in freshwater eels and other bony fishes that possess them.

Angiotensin II binding sites in the heart of Scyliorhinus canicula: an autoradiographic study

Dogfish (125)I [Asn(1), Pro(3), Ile(5)] angiotensin II ((125)I dfANG II) was used to establish the specific binding patterns of the different cardiac regions of the elasmobranch Scyliorhinus canicula by in vitro autoradiography. In the ventricular myocardium Scatchard analysis of saturation and displacement binding data revealed two classes of high- and low-affinity dfANG II binding sites (K(d) = 53 +/- 10 and 1300 +/- 900 pM). Two classes of dfANG II binding sites were also detected in the atrium (K(d) = 47 +/- 13 and 4690 +/- 930 pM) and in the outer layer of the conus arteriosus (K(d) = 16 +/- 9 and 398 +/- 83 pM). Conversely, the ventricular endocardium and the inner conal layer were characterized by a single class of dfANG II binding sites with affinity values of 48 +/- 11 and 106 +/- 3.3 pM, respectively. Competition experiments with either cold dfANG II or CV11974 or CGP42112 (specific ligands for mammalian AT(1) and AT(2) receptors, respectively) demonstrated a prevalence of CGP42112-selective dfANG II binding sites in both the inner and the outer conal layers. In the atrium, the ventricular myocardium, and the outer conal layer, dfANG II high-affinity binding sites poorly discriminated among the cold ligands. These results suggest that the dogfish heart may be a target organ of ANG II with distinct ANG II receptor subtype distributions.

Angiotensin receptors--evolutionary overview and perspectives

The structure of the angiotensin molecule has been well preserved throughout the vertebrate scale with some amino acid variations. Specific angiotensin receptors (AT receptors) that mediate important physiological functions have been noted in a variety of tissues and species. Physiological and pharmacological characterization of AT receptors and, more recently, molecular cloning studies have elucidated the presence of AT receptor subtypes. Comparative studies suggest that an AT receptor subtype homologous to the mammalian type 1 receptor subtype (AT(1)), though pharmacologically distinct, is present in amphibians and birds, whereas AT receptors cloned from teleosts show low homology to both AT(1) and AT(2) receptor subtypes. Furthermore, receptors differing from both the AT(1)-homologue receptor and AT(2) receptor exist in some non-mammalian species. This may suggest that the prototype AT receptor evolved in primitive vertebrates and diverged to more than one type of AT receptor subtype during phylogeny. Furthermore, phenotypic modulation of AT receptors appears to occur during individual development/maturation.

Angiotensin signaling and receptor types in teleost fish

Despite advances characterizing mammalian angiotensin receptors, the phylogeny of fish angiotensin receptors remains unclear. Three aspects of receptor function: (1) the nature of the ligand; (2) the second messenger system activated by it; and (3) the pharmacological profile of specific antagonists, are examined to provide insight into the fish receptor. (1) The octapeptide sequences of fish and mammalian angiotensin II (ANG II) are nearly homologous, differing only at the first and fifth residues. Both peptides are almost equally efficacious and equipotent in heterologous systems and both contain key agonist switches Tyr(4) and Phe(8) necessary to activate mammalian AT(1)-type receptors. (2) ANG II increases inositol trisphosphate production, and elevates intracellular calcium in fish tissues consistent with activation of the AT(1) receptor. (3) However, the specific mammalian sartan-type AT(1) antagonists, e.g. losartan, produce inconsistent results in fish often acting as partial agonists, or inhibiting only at elevated concentrations. Because sartans and ANG II act at distinct sites on the AT(1) receptor, we propose that the teleost receptor is an AT(1)-type receptor that is fairly well conserved with respect to both the ANG binding site and coupling to the second messenger system, whereas the sartan binding site has been poorly conserved. The evidence for non-AT(1) type ANG II receptors in teleosts is limited. Mammalian AT(2) receptor antagonists are generally ineffective but may block at elevated, non-specific doses. Truncated ANG II fragments, ANG III and ANG IV, are often less potent than ANG II, however, their receptors have not been examined. Preliminary studies in trout indicate that angiotensin 1-7 may have a mild vasodilatory effect; additional work is needed to determine if non-AT(1)-type receptors are involved.